# OnCo record paper-golfier-mol-cancer-ther (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-golfier-mol-cancer-ther/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-golfier-mol-cancer-ther" ;
  schema:name "Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect"@en ;
  schema:description "Paper cited by one treatment page, indexed on Europe PMC as PubMed record 24714131 and published in Molecular Cancer Therapeutics; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-golfier-mol-cancer-ther/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1535-7163.mct-13-0926>, <https://pubmed.ncbi.nlm.nih.gov/24714131/>, <https://europepmc.org/article/MED/24714131> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1158/1535-7163.mct-13-0926> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Golfier S, Kopitz C, Kahnert A, et al." ;
  onco:related <https://onco.cc/drugs/anetumab-ravtansine/> ;
  onco:journals <https://onco.cc/journals/molecular-cancer-therapeutics/> .